Location History:
- Sausalito, CA (US) (2003)
- Mill Valley, CA (US) (2002 - 2019)
- San Rafael, CA (US) (2010 - 2023)
Company Filing History:
14 out of 175 
4 out of 10 
3 out of 169 Years Active: 2002-2023
Title: The Innovative Contributions of Kenneth D. Rice in Cancer Research
Introduction
Kenneth D. Rice, located in San Rafael, California, has made significant contributions to the field of cancer research through his innovative work and inventions. With a robust portfolio of 23 patents, he has developed novel compounds aimed at combating proliferative diseases.
Latest Patents
Rice's latest patents include groundbreaking work on MEK inhibitors, which are crucial for the treatment of cancer. The compounds disclosed in his patent formula (I) and their pharmaceutically acceptable salts and solvates are essential for inhibiting MEK, thereby providing therapeutic options for patients suffering from proliferative diseases such as cancer. Furthermore, he has contributed to the development of solid dosage formulations of substituted quinazoline receptor-type kinase modulators. These compounds are designed to modulate receptor kinase activity, particularly ephrin and EGFR, which are vital in addressing diseases characterized by abnormal levels of cell proliferation, apoptosis, cell migration, invasion, and angiogenesis associated with tumor growth.
Career Highlights
Throughout his career, Kenneth D. Rice has held influential positions in prominent companies within the pharmaceutical industry, including Exelixis, Inc. and Symphony Evolution, Inc. His work has not only led to advancements in cancer treatment but has also cemented his reputation as a leading inventor in medical innovations.
Collaborations
Rice has collaborated with esteemed colleagues, including Tsze Tsang and Csaba J. Peto. These partnerships have fostered an environment of shared knowledge and innovation, further elevating the quality and impact of his contributions to cancer research.
Conclusion
Kenneth D. Rice's dedication to innovation in cancer treatment through his extensive patent portfolio exemplifies the critical intersection of science and medicine. His inventions not only pave the way for new therapeutic options but also inspire future research in the field.